Update: Options in Endometrial Ablation

This supplement is supported by Boston Scientific, Ethicon Women’s Health & Urology, and Hologic. It has been edited and peer reviewed by OBG MANAGEMENT.
December 1, 2009|OBG Management
Author and Disclosure Information

 

Joseph S. Sanfilippo, MD, MBA, Editor
Professor, Department of Obstetrics and Gynecology, University of Pittsburgh, Vice Chairman of Reproductive Sciences, Magee-Womens Hospital, Pittsburgh, Pennsylvania

Mark H. Glasser, MD
Chief Emeritus Department of Obstetrics & Gynecology
Kaiser Permanente Medical Center
San Rafael, California

Malcolm G. Munro, MD, FRCS(c), FACOG
Professor, Department of Obstetrics & Gynecology
David Geffen School of Medicine at UCLA
Director of Gynecologic Services
Los Angeles Medical Center
Kaiser Permanente Southern California
Los Angeles, California

Padmavathy Tummula, MD
Private practice
Banner Thunderbird Medical Center
Glendale, Arizona

 

 

 

 

Dr Sanfilippo reports that he is a consultant to Bayer HealthCare.

Dr Glasser reports that he is a consultant to and is on the speakers bureau of Boston Scientific.

Dr Munro is or has been a consultant to AMAG, Inc., Bayer HealthCare, Boston Scientific Inc, Covidien PLC, Ethicon Women’s Health & Urology, Gynesonics, Inc, Hologic, Inc., Impres Medical, and Karl Storz Endoscopy-America, Inc.

Dr Tummula has previously served as a paid consultant to Hologic, Inc.

 

 

This monograph serves as an update to the 2005 publication, “Options in endometrial ablation,” which provided brief overviews of nonresectoscopic technologies that accomplish endometrial ablation (EA) by tissue freezing, radio frequency electricity, microwaves, and heated fluid.

,false